Search research articles
Contact Us
Filters
Showing results (31-40 of 83) with videos related to
Page
of 9
Sort By:
Infection and Immunity
|
November 1, 2006
The combined CTA1-DD/ISCOMs vector is an effective intranasal adjuvant for boosting prior Mycobacterium bovis BCG immunity to Mycobacterium tuberculosis
Claire Swetman Andersen, Jes Dietrich, Else Marie Agger, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
November 30, 2010
Immunity by formulation design: induction of high CD8+ T-cell responses by poly(I:C) incorporated into the CAF01 adjuvant via a double emulsion method
Pernille Nordly, Fabrice Rose, Dennis Christensen, et al.
Immunology
|
January 19, 2008
Adjuvant modulation of the cytokine balance in Mycobacterium tuberculosis subunit vaccines; immunity, pathology and protection
Else Marie Agger, Joseph P Cassidy, Joseph Brady, et al.
Biochimica Et Biophysica Acta
|
February 12, 2008
alpha,alpha'-trehalose 6,6'-dibehenate in non-phospholipid-based liposomes enables direct interaction with trehalose, offering stability during freeze-drying
Dennis Christensen, Daniel Kirby, Camilla Foged, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
February 28, 2014
Protective CD4 T cells targeting cryptic epitopes of Mycobacterium tuberculosis resist infection-driven terminal differentiation
Joshua S Woodworth, Claus Sindbjerg Aagaard, Paul R Hansen, et al.
Angiogenesis
|
November 27, 2008
Anti-tumoral effect of active immunotherapy in C57BL/6 mice using a recombinant human VEGF protein as antigen and three chemically unrelated adjuvants
Yanelys Morera, Mónica Bequet-Romero, Marta Ayala, et al.
International Journal of Pharmaceutics
|
November 3, 2009
CAF01 liposomes as a mucosal vaccine adjuvant: In vitro and in vivo investigations
Dennis Christensen, Camilla Foged, Ida Rosenkrands, et al.
Biochimica Et Biophysica Acta
|
December 3, 2005
Characterization of cationic liposomes based on dimethyldioctadecylammonium and synthetic cord factor from M. tuberculosis (trehalose 6,6'-dibehenate)-a novel adjuvant inducing both strong CMI and antibody responses
Jesper Davidsen, Ida Rosenkrands, Dennis Christensen, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
April 13, 2010
Liposomal cationic charge and antigen adsorption are important properties for the efficient deposition of antigen at the injection site and ability of the vaccine to induce a CMI response
Malou Henriksen-Lacey, Dennis Christensen, Vincent W Bramwell, et al.
Molecular Pharmaceutics
|
December 2, 2010
Comparison of the depot effect and immunogenicity of liposomes based on dimethyldioctadecylammonium (DDA), 3β-[N-(N',N'-Dimethylaminoethane)carbomyl] cholesterol (DC-Chol), and 1,2-Dioleoyl-3-trimethylammonium propane (DOTAP): prolonged liposome retention mediates stronger Th1 responses
Malou Henriksen-Lacey, Dennis Christensen, Vincent W Bramwell, et al.
Page
of 9
Search research articles
Search
Showing results (31-40 of 83) with videos related to
Sort By:
Page
of 9
Infection and Immunity
|
November 1, 2006
The combined CTA1-DD/ISCOMs vector is an effective intranasal adjuvant for boosting prior Mycobacterium bovis BCG immunity to Mycobacterium tuberculosis
Claire Swetman Andersen, Jes Dietrich, Else Marie Agger, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
November 30, 2010
Immunity by formulation design: induction of high CD8+ T-cell responses by poly(I:C) incorporated into the CAF01 adjuvant via a double emulsion method
Pernille Nordly, Fabrice Rose, Dennis Christensen, et al.
Immunology
|
January 19, 2008
Adjuvant modulation of the cytokine balance in Mycobacterium tuberculosis subunit vaccines; immunity, pathology and protection
Else Marie Agger, Joseph P Cassidy, Joseph Brady, et al.
Biochimica Et Biophysica Acta
|
February 12, 2008
alpha,alpha'-trehalose 6,6'-dibehenate in non-phospholipid-based liposomes enables direct interaction with trehalose, offering stability during freeze-drying
Dennis Christensen, Daniel Kirby, Camilla Foged, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
February 28, 2014
Protective CD4 T cells targeting cryptic epitopes of Mycobacterium tuberculosis resist infection-driven terminal differentiation
Joshua S Woodworth, Claus Sindbjerg Aagaard, Paul R Hansen, et al.
Angiogenesis
|
November 27, 2008
Anti-tumoral effect of active immunotherapy in C57BL/6 mice using a recombinant human VEGF protein as antigen and three chemically unrelated adjuvants
Yanelys Morera, Mónica Bequet-Romero, Marta Ayala, et al.
International Journal of Pharmaceutics
|
November 3, 2009
CAF01 liposomes as a mucosal vaccine adjuvant: In vitro and in vivo investigations
Dennis Christensen, Camilla Foged, Ida Rosenkrands, et al.
Biochimica Et Biophysica Acta
|
December 3, 2005
Characterization of cationic liposomes based on dimethyldioctadecylammonium and synthetic cord factor from M. tuberculosis (trehalose 6,6'-dibehenate)-a novel adjuvant inducing both strong CMI and antibody responses
Jesper Davidsen, Ida Rosenkrands, Dennis Christensen, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
April 13, 2010
Liposomal cationic charge and antigen adsorption are important properties for the efficient deposition of antigen at the injection site and ability of the vaccine to induce a CMI response
Malou Henriksen-Lacey, Dennis Christensen, Vincent W Bramwell, et al.
Molecular Pharmaceutics
|
December 2, 2010
Comparison of the depot effect and immunogenicity of liposomes based on dimethyldioctadecylammonium (DDA), 3β-[N-(N',N'-Dimethylaminoethane)carbomyl] cholesterol (DC-Chol), and 1,2-Dioleoyl-3-trimethylammonium propane (DOTAP): prolonged liposome retention mediates stronger Th1 responses
Malou Henriksen-Lacey, Dennis Christensen, Vincent W Bramwell, et al.
Page
of 9